- Home
- CTRN vs LYEL Comparison
CTRN vs LYEL Comparison
Compare CTRN & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRN
- LYEL
- Stock Information
- Founded
- CTRN 1946
- LYEL 2018
- Country
- CTRN United States
- LYEL United States
- Employees
- CTRN N/A
- LYEL N/A
- Industry
- CTRN Clothing/Shoe/Accessory Stores
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- CTRN Consumer Discretionary
- LYEL Health Care
- Exchange
- CTRN Nasdaq
- LYEL Nasdaq
- Market Cap
- CTRN 219.8M
- LYEL 203.9M
- IPO Year
- CTRN 2005
- LYEL 2021
- Fundamental
- Price
- CTRN $26.70
- LYEL $0.58
- Analyst Decision
- CTRN Strong Buy
- LYEL Sell
- Analyst Count
- CTRN 3
- LYEL 2
- Target Price
- CTRN $27.67
- LYEL $1.00
- AVG Volume (30 Days)
- CTRN 79.3K
- LYEL 1.1M
- Earning Date
- CTRN 12-03-2024
- LYEL 02-26-2025
- Dividend Yield
- CTRN N/A
- LYEL N/A
- EPS Growth
- CTRN N/A
- LYEL N/A
- EPS
- CTRN N/A
- LYEL N/A
- Revenue
- CTRN $757,086,000.00
- LYEL $63,000.00
- Revenue This Year
- CTRN $2.02
- LYEL N/A
- Revenue Next Year
- CTRN $3.77
- LYEL N/A
- P/E Ratio
- CTRN N/A
- LYEL N/A
- Revenue Growth
- CTRN 2.00
- LYEL N/A
- 52 Week Low
- CTRN $13.66
- LYEL $0.55
- 52 Week High
- CTRN $32.90
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- CTRN 62.98
- LYEL 34.70
- Support Level
- CTRN $25.08
- LYEL $0.55
- Resistance Level
- CTRN $27.05
- LYEL $0.62
- Average True Range (ATR)
- CTRN 0.95
- LYEL 0.04
- MACD
- CTRN -0.18
- LYEL 0.01
- Stochastic Oscillator
- CTRN 82.23
- LYEL 14.24
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.